stock.name

Seres Therapeutics Inc

MCRB

Market Cap$120.1M
Close$

Compare Seres Therapeutics

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Seres Therapeutics IncSeres Therapeutics Inc-1.10%254%--2.3
marketMarket Avg59.61.27%31%6.41
HealthcareHealthcare Avg62.31.27%15%7.30.9
$3.49

Current Fair Value

346.8% upside

Undervalued by 346.8% based on the discounted cash flow analysis.

Share Statistics

Market cap$120.10 Million
Enterprise Value$93.68 Million
Dividend Yield$0.0 (0.0%)
Earnings per Share$-0.89
Beta0.62
Outstanding Shares151,009,462
Avg 30 Day Volume4,835,033

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-1.06
PEG2.64
Price to Sales-
Price to Book Ratio-0.78
Enterprise Value to Revenue0.74
Enterprise Value to EBIT-0.87
Enterprise Value to Net Income-1
Total Debt to Enterprise1.08
Debt to Equity-2.26

Revenue Sources

No data

ESG Score

No data

About Seres Therapeutics Inc

CEO: Eric Shaff